Konu "fingolimod" için Scopus İndeksli Yayınlar Koleksiyonu listeleme
Toplam kayıt 2, listelenen: 1-2
-
CXCL13 Levels Indicate Treatment Responsiveness to Fingolimod in MS Patients
(S. Karger AG, 2022)[No abstract available] -
Fingolimod for the Treatment of Relapsing-Remitting Multiple Sclerosis
(TURKISH NEUROLOGICAL SOC, 2017)Multiple sclerosis (MS) is a chronic autoimmune disease of the central nervous system and is characterized by inflammation, demyelination, and axonal loss. Fingolimod is the first oral drug for the treatment of MS approved ...